Skip to content

Comparison of oliceridine and sufentanil in total laparoscopic hysterectomy, a clinical double-blind controlled trial

Comparison of oliceridine and sufentanil in total laparoscopic hysterectomy, a clinical double-blind controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103115
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Oxalidine group:Analgesic Pump Protocol for Total Hysterectomy Loading Dose: 0.05 mg·kg-1 oliceridine postoperatively .Continuous Infusion Prepare 0.35 mg·kg-1 oliceridine diluted with normal saline t
Sufentanil group:Postoperative Analgesia Pump Protocol for Total Hysterectomy: Loading Dose:Sufentanil 0.2 µg·kg-1 administered intravenously , Continuous Infusion:Prepare sufentanil 2 µg·kg-1 diluted

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients scheduled for elective total laparoscopic hysterectomy1; 2) ASA physical status classification I-III2; 3) Age 18-65 years; 4) BMI 18-28 kg/m² with body weight >40 kg1; 5) Compliance with ethical standards and voluntary informed consent signed by participants.

Exclusion criteria

Exclusion criteria: 1?) Severe cardiac, pulmonary, hepatic, or renal dysfunction? ?2) History of psychiatric disorders or long-term use of psychotropic medications?, includes dementia, schizophrenia, chronic analgesic use, alcohol dependence, etc. 3)Patients with severe systemic infections? 4) Communication barriers or neurological dysfunction? 5) Preoperative hypoxemia? 6)Recent participation in other drug trials? within the past 30 days

Design outcomes

Primary

MeasureTime frame
Resting and movement VAS pain scores;

Secondary

MeasureTime frame
Heart Rate,Systolic Blood Pressure,Diastolic Blood Pressure,Mean Arterial Pressure;Incidence of Postoperative Adverse Events (Nausea ,Somnolenc,Respiratory depression, Pruritus);

Countries

China

Contacts

Public ContactDuan Jinjuan

Anqing Municipal Hospital

djjayd223@163.com+86 189 0966 5698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026